Community Practice

Cuts in state Medicaid payments for product reimbursements and dispensing fees are forcing pharmacists to cut services and turn away Medicaid patients.

Two counties in Wisconsin are using a reverse-distributor to round up unwanted drugs. The program, called Get the Meds Out, helps consumers in Waukesha and Winnebago Counties make free returns.

Pharmacists need to get ready now to help patients make the government-mandated switch from toxic CFC-driven MDIs to environmentally friendly HFA inhalers.

Pharmitas and U. of Washington will work together to create a medication therapy management program.

Chronic hepatitis B can now be treated with a new drug.

CVS Caremark acquires Longs Drugs, a California-based chain of 521 stores, for $2.9 billion.

The ban, the first of its kind in the nation, is set to take effect Oct. 1.

The products will be stocked in the retail chain's digestive section.

Mandate comes in regard to the risk of invasive fungal infections.

Drug may become the first approved once-daily therapy to treat advanced kidney cancer.

The government claimed that Doug Albers and his wholesale business, Albers Medical Distributors, grossed $26.3 million in fake or stolen drugs.

Thirty-one percent of pharmacists surveyed said PhRMA's new marketing code is long overdue.

The groups have signed a two-year agreement.

Online pharmacy sales during the past year tripled to $12 billion.

The drug is marketed in Japan to treat low blood pressure.

The law means North Dakota consumers must travel elsewhere to buy the more than 300 drugs retailers like Wal-Mart and Target offer for $4.

The Wilson Rx Pharmacy Satisfaction Survey Report indicates pharmacy customers see convenience, price, and overall pharmacy services as key to customer satisfaction.

FDA scrutinizes Byetta, a diabetes drug from Eli Lilly and Amylin, following reports of deaths.

Goal is to identify potential health risks for these groups of women.

Shopko, a discount retailer, donated $1 million.

California was directed by the Federal District Court in Los Angeles to stop the 10 percent cuts in Medi-Cal reimbursement payments to healthcare providers.

The study investigated whether individuals in low-income areas are more strongly influenced by rising prescription drug co-payments than individuals in higher income areas.

The collaboration will study genetic testing and the impact of genetics on the efficacy of prescription drugs.

This year's prescription drug ads are not really impacting consumers.

Consumers can take their unused or unwanted drugs back to their pharmacies.